Medicamen Biotech Financials
NSE: MEDICAMEQ | BSE: 531146
₹270.25
₹10.85
(4.18%)
As on 04-Sep-2026 15:55IST
Market cap
₹367 Cr
Revenue (TTM)
₹203 Cr
P/E Ratio
33.9
P/B Ratio
1.4
Div. Yield
0.4 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
202.62
|
162.55
|
179.31
|
140.87
|
115.45
|
112.72
|
|
|
|
|
|
|
Total Income
|
206.13
|
168.80
|
181.63
|
143.33
|
117.17
|
113.47
|
|
|
|
|
|
|
Total Expenditure
|
183.32
|
148.13
|
155.79
|
116.53
|
91.36
|
93.04
|
|
|
|
|
|
|
EBITDA
|
19.30
|
14.42
|
23.51
|
24.34
|
24.09
|
19.67
|
|
|
|
|
|
|
Depreciation
|
7.20
|
7.07
|
7.09
|
6.37
|
5.77
|
2.52
|
|
|
|
|
|
|
EBIT
|
12.09
|
7.35
|
16.42
|
17.97
|
18.32
|
17.15
|
|
|
|
|
|
|
Interest
|
3.17
|
3.72
|
5.67
|
3.39
|
1.94
|
1.51
|
|
|
|
|
|
|
Other Income
|
3.51
|
6.25
|
2.33
|
2.46
|
1.72
|
0.75
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
12.43
|
9.88
|
13.08
|
17.05
|
18.09
|
16.39
|
|
|
|
|
|
|
Provision for Tax
|
2.38
|
3.32
|
3.58
|
2.32
|
3.20
|
4.26
|
|
|
|
|
|
|
Profit after Tax
|
10.04
|
6.56
|
9.49
|
14.73
|
14.90
|
12.13
|
|
|
|
|
|
|
Minority Interest
|
0.79
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
10.83
|
6.56
|
9.49
|
14.73
|
14.90
|
12.13
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
275.55
|
213.05
|
206.98
|
193.41
|
146.47
|
132.89
|
|
|
|
|
|
|
Minority Interest
|
0.79
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
8.52
|
3.11
|
0.50
|
0.65
|
6.04
|
7.84
|
|
|
|
|
|
|
Current Liabilities
|
87.92
|
78.16
|
84.56
|
82.57
|
72.69
|
53.27
|
|
|
|
|
|
|
Total Liabilities
|
371.99
|
297.15
|
294.55
|
278.52
|
225.69
|
194.01
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
92.79
|
122.99
|
125.74
|
106.22
|
94.42
|
91.31
|
|
|
|
|
|
|
Current Assets
|
223.73
|
164.55
|
159.59
|
163.36
|
123.04
|
96.03
|
|
|
|
|
|
|
Total Assets
|
371.99
|
297.15
|
294.55
|
278.52
|
225.69
|
194.01
|
|
|
|
|
|
|
Total Debt*
|
--
|
33.77
|
31.11
|
25.71
|
25.80
|
18.82
|
|
|
|
|
|
|
Net Current Assets
|
135.81
|
86.39
|
75.04
|
80.79
|
50.35
|
42.76
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-8.16
|
-6.74
|
-6.29
|
4.11
|
12.77
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-1.40
|
-5.56
|
-5.88
|
-8.47
|
-17.81
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-1.47
|
6.31
|
29.13
|
4.30
|
5.84
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-11.03
|
-5.99
|
16.95
|
-0.07
|
0.80
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
7.98
|
5.16
|
7.47
|
11.64
|
12.19
|
9.93
|
|
|
|
|
|
|
Cash EPS (₹)
|
7.98
|
10.71
|
13.05
|
16.67
|
16.92
|
11.99
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
199.52
|
162.23
|
157.52
|
145.25
|
113.56
|
103.33
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.37
|
1.00
|
1.00
|
1.00
|
1.00
|
1.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
-6.42
|
-5.30
|
-4.97
|
3.36
|
10.45
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-11.77
|
-13.54
|
-11.29
|
-4.71
|
-4.84
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
5.77
|
8.46
|
10.85
|
12.94
|
12.99
|
|
|
|
|
|
|
ROE (%)
|
3.93
|
3.23
|
4.94
|
9.13
|
11.25
|
9.89
|
|
|
|
|
|
|
ROA (%)
|
3.00
|
2.24
|
3.34
|
5.87
|
7.11
|
6.46
|
|
|
|
|
|
|
EBIT Margin (%)
|
5.97
|
4.52
|
9.16
|
12.76
|
15.87
|
15.22
|
|
|
|
|
|
|
Net Margin (%)
|
4.87
|
3.88
|
5.23
|
10.28
|
12.72
|
10.69
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
8.38
|
9.25
|
14.98
|
17.90
|
13.00
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
24.66
|
-9.35
|
27.29
|
22.02
|
2.42
|
-10.19
|
|
|
|
|
|
|
EBIT Growth (%)
|
52.44
|
-55.23
|
-8.64
|
-1.86
|
6.79
|
1.05
|
|
|
|
|
|
|
Net Profit Growth (%)
|
13.97
|
-30.95
|
-35.54
|
-1.14
|
22.82
|
-8.74
|
|
|
|
|
|
|
EPS Growth (%)
|
8.41
|
-30.95
|
-35.86
|
-4.53
|
22.82
|
-8.74
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
2.99
|
8.99
|
32.45
|
9.91
|
5.92
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
33.89
|
93.43
|
51.31
|
56.31
|
52.79
|
53.78
|
|
|
|
|
|
|
Price / Book Value
|
1.36
|
2.97
|
2.43
|
4.51
|
5.67
|
5.17
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.37
|
0.21
|
0.26
|
0.15
|
0.16
|
0.19
|
|
|
|
|
|
|
EV/EBITDA
|
16.82
|
31.09
|
19.48
|
31.13
|
31.32
|
32.67
|
|
|
|
|
|
|
Close Price (₹)
|
250.20
|
480.00
|
383.90
|
658.90
|
640.85
|
534.00
|
|
|
|
|
|
|
High Price (₹)
|
454.00
|
630.00
|
903.50
|
1,225.00
|
1,023.25
|
665.00
|
|
|
|
|
|
|
Low Price (₹)
|
212.40
|
375.05
|
355.45
|
557.20
|
460.00
|
177.10
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
366.94
|
612.46
|
487.10
|
829.34
|
786.38
|
652.37
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.02
|
0.16
|
0.16
|
0.14
|
0.19
|
0.15
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.14
|
0.14
|
0.12
|
0.13
|
0.08
|
|
|
|
|
|
|
Current Ratio
|
2.54
|
2.11
|
1.89
|
1.98
|
1.69
|
1.80
|
|
|
|
|
|
|
Quick Ratio
|
1.75
|
1.31
|
1.31
|
1.50
|
1.36
|
1.70
|
|
|
|
|
|
|
Interest Coverage
|
4.92
|
3.66
|
3.31
|
6.03
|
10.32
|
11.85
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
40.38
|
42.39
|
30.82
|
46.33
|
54.76
|
46.62
|
|
|
|
|
|
|
Asset Turnover
|
0.61
|
0.55
|
0.63
|
0.56
|
0.55
|
0.60
|
|
|
|
|
|
|
Receivable days
|
--
|
139.40
|
122.66
|
166.45
|
183.01
|
165.97
|
|
|
|
|
|
|
Inventory Days
|
--
|
136.43
|
106.29
|
93.37
|
50.92
|
35.88
|
|
|
|
|
|
|
Payable days
|
--
|
226.08
|
215.82
|
311.49
|
316.67
|
253.69
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
49.75
|
13.14
|
-51.67
|
-82.73
|
-51.84
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
